PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 18 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Anhydrolycorinium chloride showed 64-69% life extension in vivo at doses of 10 to 20 mg/kg; acetylcaranine and ambelline showed in vitro activity [PMID:6512532].
The lycorane-type alkaloid acetylcaranine exhibited strong antiplasmodial activity in vitro [PMID:29162457].
Chloroform extracts and the alkaloid buphanidrine demonstrated inhibitory activity against AChE in vitro [PMID:33459053].
In vitro assays showed montanine was active against HCT-116, MDAMB231, and Hs578T cell lines, while lycorine was most active against MCF-7 [PMID:38614259].
The protein amaryllin showed antifungal activity against these species [PMID:19478451].
Evidence summary
PubMed sources
- 1.PMID: 6512532 (1984) — Antineoplastic agents, 99. Amaryllis belladonna. · Journal of natural products
- 2.PMID: 28858260 (2017) — Alkaloid Constituents of the Amaryllidaceae Plant Amaryllis belladonna L. · Molecules (Basel, Switzerland)
- 3.PMID: 33459053 (2022) — Acetylcholinesterase inhibitory activity from Amaryllis belladonna growing in Chile: enzymatic and molecular docking studies. · Natural product research
- 4.PMID: 29162457 (2018) — Antiplasmodial alkaloids from bulbs of Amaryllis belladonna Steud. · Bioorganic & medicinal chemistry letters
- 5.PMID: 34790872 (2021) — The complete plastome of the South African species, Amaryllis belladonna L. (Amaryllidaceae).